Medicare Enrolled
Dr. Rajeev Grover, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Grover from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grover?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grover
Dr. Rajeev Grover is a cardiovascular disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Grover performed 4,464 Medicare services across 1,608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grover received a total of $5,134 from 36 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grover is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in TX
$5,134 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,464
Medicare services
Top 21% in TX for cardiovascular disease
1,608
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~223 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
814 | $39 | $140 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
806 | $32 | $160 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
701 | $40 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
660 | $101 | $330 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
398 | $11 | $52 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
238 | $158 | $704 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
180 | $45 | $76 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
115 | $98 | $322 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
94 | $157 | $623 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
75 | $141 | $445 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $72 | $224 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
48 | $66 | $180 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 46 | $767 | $978 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
45 | $1,981 | $4,786 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
45 | $149 | $360 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
45 | $58 | $200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
24 | $16 | $40 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $143 | $625 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $134 | $504 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
11 | $68 | $273 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
11 | $196 | $797 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
11 | $157 | $606 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.4% high complexity
8.9% medium
84.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,134
Total received (2018-2024)
Avg $733/year across 7 years
Top 49% in TX for cardiovascular disease
36
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,946 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$188 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$726
2023
$866
2022
$829
2021
$789
2020
$341
2019
$762
2018
$821
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$824
Amarin Pharma Inc.
$496
Boehringer Ingelheim Pharmaceuticals, Inc.
$452
PFIZER INC.
$430
Amgen Inc.
$424
Merck Sharp & Dohme LLC
$381
Janssen Pharmaceuticals, Inc
$321
Boston Scientific Corporation
$315
Lundbeck LLC
$217
E.R. Squibb & Sons, L.L.C.
$145
Edwards Lifesciences Corporation
$115
Abbott Laboratories
$103
BOSTON SCIENTIFIC CORPORATION
$102
AstraZeneca Pharmaceuticals LP
$101
Gilead Sciences, Inc.
$77
Medicure Pharma Inc.
$69
Regeneron Healthcare Solutions, Inc.
$65
Esperion Therapeutics, Inc.
$65
AGEPHA Pharma FZ LLC
$45
Otsuka America Pharmaceutical, Inc.
$43
Merck Sharp & Dohme Corporation
$37
Kowa Pharmaceuticals America, Inc.
$33
Allergan Inc.
$27
Impulse Dynamics (USA) Inc.
$27
Medtronic, Inc.
$22
ARALEZ PHARMACEUTICALS US INC.
$22
SANOFI-AVENTIS U.S. LLC
$22
Avinger Inc.
$21
ABIOMED
$21
HeartFlow, Inc.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Lexicon Pharmaceuticals, Inc.
$18
Lupin Inc.
$16
Coala Life Inc
$15
Cook Medical LLC
$14
MEDICOMP INC
$11
Top 3 companies account for 34.5% of total payments
Associated products mentioned in payments ›
ANTARA · Azure · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · Coala Heart Monitor · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EnSite Velocity System Mapping Disposables · Ensite Cardiac Mapping System · FARXIGA · FFRct · General - Tachy · HeartMate 3 Left Ventricular Dev · Impella · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LODOCO · LifeVest · Livalo · MULTAQ · Mitra Clip system · NEXLETOL · NORTHERA · OPTIMIZER · PANTHERIS · PRADAXA · PRALUENT · RHYTHMIA · Repatha · SAMSCA · SAPIEN 3 Ultra RESILIA · TELEPATCH CARDIAC MONITOR · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZILVER PTX · ZONTIVITY · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $115 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
314
Per 100K population
6.6
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grover is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grover experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Grover performed 814 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grover receive payments from pharmaceutical companies?
Yes. Dr. Grover received a total of $5,134 from 36 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grover's costs compare to other cardiologists in Houston?
Dr. Grover's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grover) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology